الابحاث

South Egypt Cancer Institute

Assiut University

Department of Medical Oncology
# Title Research Member Research Year
11 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Prof. Ashraf Zeidan Abdalla Ahmed 2023
12 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Amany Mohammed Abdel Moatamed 2023
13 Tumor Lymphocytic Infiltration as a Prognostic Factor in Gastric Carcinoma Prof. Ashraf Zeidan Abdalla Ahmed 2023
14 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Dr. Salah Mabrouk Khallaf Abd Rabou 2023
15 Tumor Lymphocytic Infiltration as a Prognostic Factor in Gastric Carcinoma Dr. Marwa Tammam Ameen Hammam 2023
16 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Dr. Shimaa Hassan Shabaan Hassan 2023
17 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Dr. Salah Mabrouk Khallaf Abd Rabou 2021
18 Role of Metastatic Colon Cancer Topography in Pathological and Molecular Variability : A Retrospective Study Dr. Adel Gomaa Mohamed Gabr 2021
19 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Dr. Ahmed Mohammed Morsy Hassan 2021
20 Laparoscopic versus Open Complete Mesocolic Excision for Right Colon Cancer Dr. Salah Mabrouk Khallaf Abd Rabou 2021